Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigmentosa (RP).
Aug 20, 2012
1
2
Disorders of the eye are excellent targets for gene therapy because the ocular environment is readily accessible, relatively easy to monitor, and sequestered from the rest of the body. A series of articles available online ...
May 9, 2011
0
0
More than 15 million Americans suffer from age-related macular degeneration, a disease that can rob patients of their sight. It starts slowly. Over the course of months or years, lumps of cellular debris and new blood vessels ...
Oct 6, 2015
0
319
A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness. This hyper-targeted approach offers hope to individuals living with spinocerebellar ataxia ...
Nov 1, 2018
0
86
After a lengthy study spanning over four years, Professor Pauline Cho from the School of Optometry at The Hong Kong Polytechnic University (PolyU) and her research team concluded that orthokeratology not only can correct ...
Jan 11, 2012
0
0
Researchers in Oxford have carried out the world's first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD), the UK's most common cause of sight loss.
Feb 19, 2019
0
5
Silencing a gene called Nrl in mice prevents the loss of cells from degenerative diseases of the retina, according to a new study. The findings could lead to novel therapies for preventing vision loss from human diseases ...
Mar 14, 2017
0
119
Under the direction of Boyd Professor Nicolas Bazan, MD, Ph.D., scientists at LSU Health New Orleans Neuroscience Center of Excellence have developed a new, experimental human cell line from retinal pigment epithelial cells. ...
Jul 12, 2022
0
71
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Feb 7, 2020
0
16
A metabolite of caffeine, known as 7-MX, may slow the progression of short-sightedness, also known as myopia, in children, suggests observational research published online in the British Journal of Ophthalmology.
Aug 22, 2022
0
50
